Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
568. Hiemke C, Dragicevic A, Kuss HJ, Rao ML, Shams J, Müller MJ. TDM zur Optimierung <strong>de</strong>r<br />
anti<strong>de</strong>pressiven Pharmakotherapie. Med Welt 2005;56:338-40.<br />
569. Thürmann PA. Geschlechtsspezifische Unterschie<strong>de</strong> bei Arzneimitteln. Ther Umsch<br />
2007;64(6):325-9.<br />
570. Licht RW, Qvitzau S. Treatment strategies in patients with major <strong>de</strong>pression not responding to<br />
first-line sertraline treatment. A randomised study of exten<strong>de</strong>d duration of treatment, dose<br />
increase or mianserin augmentation. Psychopharmacology (Berl) 2002;161(2):143-51.<br />
571. Adli M, Baethge C, Heinz A, Langlitz N, Bauer M. Is dose escalation of anti<strong>de</strong>pressants a<br />
rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch<br />
Psychiatry Clin Neurosci 2005;255(6):387-400.<br />
572. Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory<br />
major <strong>de</strong>pression. Curr Pharm Des 2006;12(23):2985-92.<br />
573. Bauer M, Dopfmer S. Lithium augmentation in treatment-resistant <strong>de</strong>pression: meta-analysis<br />
of placebo-controlled studies. J Clin Psychopharmacol 1999;19(5):427-34.<br />
574. Bauer M, Adli M, Baethge C, Berghofer A, Sasse J, Heinz A, Bschor T. Lithium augmentation<br />
therapy in refractory <strong>de</strong>pression: clinical evi<strong>de</strong>nce and neurobiological mechanisms. Can J<br />
Psychiatry 2003;48(7):440-8.<br />
575. Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE,<br />
War<strong>de</strong>n D, Luther JF, Nie<strong>de</strong>rehe G, Lebowitz B, Shores-Wilson K, Rush AJ. A comparison of<br />
lithium and T(3) augmentation following two failed medication treatments for <strong>de</strong>pression: a<br />
STAR*D report. Am J Psychiatry 2006;163(9):1519-30.<br />
576. Nelson JC. Treatment of anti<strong>de</strong>pressant nonrespon<strong>de</strong>rs: augmentation or switch? J Clin<br />
Psychiatry 1998;59 Suppl 15:35-41.<br />
577. Shelton C, Entsuah R, Padmanabhan SK, Vinall PE. Venlafaxine XR <strong>de</strong>monstrates higher<br />
rates of sustained remission compared to fluoxetine, paroxetine or placebo. Int Clin<br />
Psychopharmacol 2005;20(4):233-8.<br />
578. Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G. A randomized, doubleblind<br />
comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and<br />
venlafaxine in treatment-resistant <strong>de</strong>pression. Depress Anxiety 2006;23(6):364-72.<br />
579. Ferreri M, Lavergne F, Berlin I, Payan C, Puech AJ. Benefits from mianserin augmentation of<br />
fluoxetine in patients with major <strong>de</strong>pression non-respon<strong>de</strong>rs to fluoxetine alone. Acta Psychiatr<br />
Scand 2001;103(1):66-72.<br />
580. Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of anti<strong>de</strong>pressant<br />
augmentation with mirtazapine. Biol Psychiatry 2002;51(2):183-8.<br />
581. Dam J, Ry<strong>de</strong> L, Svejso J, Lauge N, Lauritsen B, Bech P. Morning fluoxetine plus evening<br />
mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major<br />
<strong>de</strong>pression. Pharmacopsychiatry 1998;31(2):48-54.<br />
582. Debonnel G, Gobbi G, Turcotte J, Boucher N, Herbert C, <strong>de</strong> Montigny C, Blier P. Effects of<br />
mirtazapine, paroxetine and their combination: a double-blind study in major <strong>de</strong>pression. Eur<br />
Neuropsychopharmacol 2000;10:252.<br />
583. Lauritzen L, Clemmesen L, Klysner R, Loldrup D, Lun<strong>de</strong> M, Schaumburg E, Waarst S, Bech<br />
P. Combined treatment with imipramine and mianserin. A controlled pilot study.<br />
Pharmacopsychiatry 1992;25(4):182-6.<br />
584. Maes M, Libbrecht I, van HF, Campens D, Meltzer HY. Pindolol and mianserin augment the<br />
anti<strong>de</strong>pressant activity of fluoxetine in hospitalized major <strong>de</strong>pressed patients, including those<br />
with treatment resistance. J Clin Psychopharmacol 1999;19(2):177-82.<br />
585. Medhus A, Heskestad S, Tjemsland L. Mianserin ad<strong>de</strong>d to tricyclic anti<strong>de</strong>pressants in<br />
<strong>de</strong>pressed patients not responding to a tricyclic anti<strong>de</strong>pressant alone: a randomized, placebocontrolled,<br />
double-blind study. Nord J Psychiatry 1994;48:355-8.<br />
586. <strong>de</strong> Lima MS, Hotoph M, Wessely S. The efficacy of drug treatments for dysthymia: a<br />
systematic review and meta-analysis. Psychol Med 1999;29(6):1273-89.<br />
© 2009 230